Oncology & Cancer

Why cancer immunotherapies don't work for everyone

A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.

Oncology & Cancer

Discovery points to new approach to treating liver cancer

A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer ...

page 7 from 40